Evonik Evonik

X

Find Fosravuconazole manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Fosravuconazole
Also known as: 351227-64-0, Fosravuconazole [inn], Bms-379224, Ravuconazole phosphoester, Ravuconazole methylphosphate, E1224 free acid
Molecular Formula
C23H20F2N5O5PS
Molecular Weight
547.5  g/mol
InChI Key
SYTNEMZCCLUTNX-NPMXOYFQSA-N
FDA UNII
L4Q6O5430L

Fosravuconazole is under investigation in clinical trial NCT03378661 (BENDITA BEnznidazole New Doses Improved Treatment and Associations).
1 2D Structure

Fosravuconazole

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-yl]oxymethyl dihydrogen phosphate
2.1.2 InChI
InChI=1S/C23H20F2N5O5PS/c1-15(22-29-21(10-37-22)17-4-2-16(9-26)3-5-17)23(11-30-13-27-12-28-30,34-14-35-36(31,32)33)19-7-6-18(24)8-20(19)25/h2-8,10,12-13,15H,11,14H2,1H3,(H2,31,32,33)/t15-,23+/m0/s1
2.1.3 InChI Key
SYTNEMZCCLUTNX-NPMXOYFQSA-N
2.1.4 Canonical SMILES
CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)OCOP(=O)(O)O
2.1.5 Isomeric SMILES
C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)OCOP(=O)(O)O
2.2 Other Identifiers
2.2.1 UNII
L4Q6O5430L
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Bms-379224

2.3.2 Depositor-Supplied Synonyms

1. 351227-64-0

2. Fosravuconazole [inn]

3. Bms-379224

4. Ravuconazole Phosphoester

5. Ravuconazole Methylphosphate

6. E1224 Free Acid

7. Ravuconazole Methyl Phosphate

8. E-1224 Free Acid

9. Chebi:34549

10. L4q6o5430l

11. Bms 379224

12. (((2r,3r)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)butan-2-yl)oxy)methyl Dihydrogen Phosphate

13. Benzonitrile, 4-(2-((1r,2r)-2-(2,4-difluorophenyl)-1-methyl-2-((phosphonooxy)methoxy)-3-(1h-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)-

14. Unii-l4q6o5430l

15. Fosravuconazole [mi]

16. Chembl333325

17. Schembl1434200

18. Fosravuconazole [who-dd]

19. Dtxsid70188627

20. Db15204

21. [(2r,3r)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-yl]oxymethyl Dihydrogen Phosphate

22. Hy-16779

23. Cs-0012407

24. Q27116141

25. 4-[2-[(1r,2r)-1-methyl-2-(phosphonooxymethoxy)-2-(2,4-difluorophenyl)-3-(1h-1,2,4-triazole-1-yl)propyl]thiazole-4-yl]benzonitrile

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 547.5 g/mol
Molecular Formula C23H20F2N5O5PS
XLogP32.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count12
Rotatable Bond Count10
Exact Mass547.08908325 g/mol
Monoisotopic Mass547.08908325 g/mol
Topological Polar Surface Area172 Ų
Heavy Atom Count37
Formal Charge0
Complexity859
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 ATC Code

D - Dermatologicals

D01 - Antifungals for dermatological use

D01B - Antifungals for systemic use

D01BA - Antifungals for systemic use

D01BA03 - Fosravuconazole


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY